SAVIMS

Other scientific evidence

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Understanding the Pfizer-BioNTech COVID-19 Vaccine: What You Need to Know

Reference: U.S. Department of Health and Human Services. (2021). Fact sheet for recipients and caregivers: Emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19) in individuals 12 years of age and older. Retrieved from www.cvdvaccine.com Summary: The Pfizer-BioNTech COVID-19 Vaccine is offered under emergency use authorization (EUA) to prevent […]

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Comprehensive Overview of the FLCCC COVID-19 Management Protocol

Reference: Marik, P. (2021). FLCCC Alliance – COVID-19 Management Protocol (06-21-2021). Retrieved from www.flccc.net Summary: The FLCCC Alliance’s COVID-19 Management Protocol provides a multifaceted approach to treating COVID-19, focusing on prevention and early intervention to mitigate severe disease outcomes. The protocol outlines three key treatment strategies: MATH+, I-MASK+, and I-RECOVER, tailored to different stages of

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Long Haul COVID-19 Syndrome: Management and Treatment Protocols

Reference: Front Line COVID-19 Critical Care Alliance. (2021). Prevention & treatment protocols for COVID-19: Management protocol for Long Haul COVID-19 Syndrome (LHCS). Retrieved from https://flccc.net/flccc-protocols-a-guide-to-the-management-of-covid-19 Summary: The Front Line COVID-19 Critical Care Alliance (FLCCC) has developed a consensus protocol for managing Long Haul COVID-19 Syndrome (LHCS), which presents a range of symptoms including fatigue, cognitive

Other scientific evidence, Resource Type, Treatment

Human Cells Can Rewrite RNA into DNA: A Groundbreaking Discovery

Reference: Rees, V. (2021, June 14). Human cells can write RNA sequences into DNA, study shows. Drug Target Review. https://www.drugtargetreview.com/news/92931/human-cells-can-write-rna-sequences-into-dna-study-shows/ Summary: Researchers at Thomas Jefferson University have discovered that human polymerase theta can convert RNA segments back into DNA, challenging the traditional understanding of molecular biology. This finding suggests that RNA messages may serve as

Ethics, Other scientific evidence, Reference Library, Resource Type

The Heartbreaking Reality of South Africa’s Healthcare System

Reference: De Maayer, T. (2022). How do you manage to come to work every day, fail at your job of ensuring basic healthcare for the people you serve and still sleep at night? DM168. Summary: In a poignant open letter, Dr Tim De Maayer, a paediatrician at Rahima Moosa Mother and Child Hospital, sheds light

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Dr Chetty’s 8th Day Therapy for COVID-19: A Summary

Reference: Chetty, S. (2021). Dr Chetty’s 8th day therapy for COVID-19. Covexit. Retrieved from [URL] Summary: Dr Shankara Chetty’s 8th Day Therapy for COVID-19 addresses the inflammatory phase occurring after Day 8 of infection, aiming to prevent severe disease progression. The document outlines four key interventions starting at this critical juncture. First, corticosteroids like Prednisone

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

I-MASS Protocol for COVID-19 Treatment

Reference: FLCCC Alliance. (2021). I-MASS protocol. Retrieved from https://flccc.net/covid-19-protocols/ Summary: The I-MASS protocol, developed by the Front Line COVID-19 Critical Care Alliance (FLCCC), outlines prevention and treatment strategies for COVID-19, particularly focusing on home treatment and mass distribution during outbreaks. For prevention, adults over 18 years are advised to take Ivermectin (18 mg weekly), Vitamin

COVID-19, Covid-19 vaccines, Ethics, Genetic vaccines, Other scientific evidence, Reference Library, Resource Type, Vaccines, Viral illnesses

Merriam-Webster Updates Definition of “Vaccine”

Reference: Mair, V. (2021, April 30). Merriam-Webster gives “vaccine” a new definition. Language Log. Retrieved from https://languagelog.ldc.upenn.edu/nll/?p=50886 Summary: In a recent post, Victor Mair discusses an update to the definition of “vaccine” by Merriam-Webster. While traditional definitions describe vaccines as preparations of weakened or killed pathogens, the new entry expands this definition significantly. It now

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Ethics, Other scientific evidence, Reference Library, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Monitoring the Effectiveness of the Ad26.COV2.S COVID-19 Vaccine in South African Healthcare Workers

Reference: South African Medical Research Council. (2021). Sisonke Protocol Version 4.4 dated 29 Apr 2021. Summary: The Sisonke Protocol is an open-label, single-arm phase 3B study aimed at evaluating the effectiveness of the Ad26.COV2.S COVID-19 vaccine among healthcare workers in South Africa. This study involves approximately 500,000 healthcare workers aged 18 and older, who will

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Analysis of Adverse Drug Reactions for Covid-19 Vaccines

Reference: VigiAccess. (2021). VigiAccess™. Retrieved from https://who-umc.org Summary: VigiAccess provides a comprehensive overview of adverse drug reactions (ADRs) associated with Covid-19 vaccines, highlighting a total of 2,183,912 reports. The data illustrates the geographical distribution of ADRs, with significant counts reported across continents such as the Americas, Europe, and Asia. The analysis categorises ADRs into various

Scroll to Top